EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Targeting epigenetic modifications in Parkinson's disease therapy

Dan Zhang, Jifa Zhang, Yuxi Wang, Guan Wang, Pan Tang, Yun Liu, Yiwen Zhang, Liang Ouyang iD

Medicinal Research Reviews · 2023-09 · 43 (5) · 1748-1777

DOI: 10.1002/med.21962 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Medicinal Research Reviews, online erschienen am 29.04.2023. Verfasst von Dan Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy and Joint Research Institution of Altitude Health and National Clinica…. Hauptthemen laut MEDLINE: Parkinson Disease, MicroRNAs. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 227 Literaturangaben. Gefördert von: National Natural Science Foundation of China, China Postdoctoral Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Parkinson's disease (PD) is a multifactorial disease due to a complex interplay between genetic and epigenetic factors. Recent efforts shed new light on the epigenetic mechanisms involved in regulating pathways related to the development of PD, including DNA methylation, posttranslational modifications of histones, and the presence of microRNA (miRNA or miR). Epigenetic regulators are potential therapeutic targets for neurodegenerative disorders. In the review, we aim to summarize mechanisms of epigenetic regulation in PD, and describe how the DNA methyltransferases, histone deacetylases, and histone acetyltransferases that mediate the key processes of PD are attractive therapeutic targets. We discuss the use of inhibitors and/or activators of these regulators in PD models or patients, and how these small molecule epigenetic modulators elicit neuroprotective effects. Further more, given the importance of miRNAs in PD, their contributions to the underlying mechanisms of PD will be discussed as well, together with miRNA‐based therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseMicroRNAsHumansEpigenesis, GeneticDNA MethylationHistones

Stichwörter der Autor:innen

DNA methyltransferaseParkinson's disease (PD)epigeneticshistone deacetylasesmiRNA

Substanzen

HistonesMicroRNAs

Autor:innen und Institutionen

  • Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy and Joint Research Institution of Altitude Health and National Clinical Research Center for Geriatrics,West China Hospital, Sichuan Universi…
  • Targeted Tracer Research and Development Laboratory, Institute of Respiratory Health, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, Sichuan, China.

ORCID-Profile: Liang Ouyang

Förderung

  • National Natural Science Foundation of China
  • China Postdoctoral Science Foundation

Zitieren

APA

Zhang, D., Zhang, J., Wang, Y., Wang, G., Tang, P., Liu, Y., Zhang, Y., & Ouyang, L. (2023). Targeting epigenetic modifications in Parkinson's disease therapy. Medicinal Research Reviews, 43(5), 1748-1777. https://doi.org/10.1002/med.21962

Vancouver

Zhang D, Zhang J, Wang Y, Wang G, Tang P, Liu Y, et al. Targeting epigenetic modifications in Parkinson's disease therapy. Medicinal Research Reviews. 2023;43(5):1748-1777. doi:10.1002/med.21962

BibTeX
@article{Zhang2023,
  author = {Zhang, Dan and Zhang, Jifa and Wang, Yuxi and Wang, Guan and Tang, Pan and Liu, Yun and Zhang, Yiwen and Ouyang, Liang},
  title = {Targeting epigenetic modifications in Parkinson's disease therapy},
  journal = {Medicinal Research Reviews},
  year = {2023},
  volume = {43},
  number = {5},
  pages = {1748--1777},
  doi = {10.1002/med.21962}
}
Kostenlos starten →